LU91711I2 - Conugé analogue de la gonadolibérine (GnRF-gonadotrophin releasing factor)-anatoxine diphtérique adsorbé sur un polysaccharide ionique ladite gonadolibérine étant également connue sous le nom d'hormone stimulant la sécrétion des hormones gonadotropes(GnRH) ou encore sous le nom d'hormone stimulant la sécrétion de l'hormone luténisante (LHRH)(IMPROVAC). - Google Patents

Conugé analogue de la gonadolibérine (GnRF-gonadotrophin releasing factor)-anatoxine diphtérique adsorbé sur un polysaccharide ionique ladite gonadolibérine étant également connue sous le nom d'hormone stimulant la sécrétion des hormones gonadotropes(GnRH) ou encore sous le nom d'hormone stimulant la sécrétion de l'hormone luténisante (LHRH)(IMPROVAC).

Info

Publication number
LU91711I2
LU91711I2 LU91711C LU91711C LU91711I2 LU 91711 I2 LU91711 I2 LU 91711I2 LU 91711 C LU91711 C LU 91711C LU 91711 C LU91711 C LU 91711C LU 91711 I2 LU91711 I2 LU 91711I2
Authority
LU
Luxembourg
Prior art keywords
hormone
gonadotropin
releasing
secretion
stimulating
Prior art date
Application number
LU91711C
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU91711I2 publication Critical patent/LU91711I2/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
LU91711C 1997-07-09 2010-07-28 Conugé analogue de la gonadolibérine (GnRF-gonadotrophin releasing factor)-anatoxine diphtérique adsorbé sur un polysaccharide ionique ladite gonadolibérine étant également connue sous le nom d'hormone stimulant la sécrétion des hormones gonadotropes(GnRH) ou encore sous le nom d'hormone stimulant la sécrétion de l'hormone luténisante (LHRH)(IMPROVAC). LU91711I2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPO7768A AUPO776897A0 (en) 1997-07-09 1997-07-09 A method of achieving production gains in livestock and agents useful for same
PCT/AU1998/000532 WO1999002180A1 (fr) 1997-07-09 1998-07-09 Composition immunogene de lh-rh et procedes concernant cette composition

Publications (1)

Publication Number Publication Date
LU91711I2 true LU91711I2 (fr) 2010-09-28

Family

ID=3802056

Family Applications (1)

Application Number Title Priority Date Filing Date
LU91711C LU91711I2 (fr) 1997-07-09 2010-07-28 Conugé analogue de la gonadolibérine (GnRF-gonadotrophin releasing factor)-anatoxine diphtérique adsorbé sur un polysaccharide ionique ladite gonadolibérine étant également connue sous le nom d'hormone stimulant la sécrétion des hormones gonadotropes(GnRH) ou encore sous le nom d'hormone stimulant la sécrétion de l'hormone luténisante (LHRH)(IMPROVAC).

Country Status (19)

Country Link
US (6) US7534441B2 (fr)
EP (4) EP2196213A1 (fr)
JP (3) JP5116916B2 (fr)
KR (2) KR100680631B1 (fr)
AT (1) ATE458493T1 (fr)
AU (2) AUPO776897A0 (fr)
CA (1) CA2294865C (fr)
CY (2) CY1109968T1 (fr)
DE (2) DE122010000033I1 (fr)
DK (1) DK1007084T3 (fr)
ES (1) ES2339308T3 (fr)
FR (2) FR10C0035I2 (fr)
LU (1) LU91711I2 (fr)
NZ (1) NZ502080A (fr)
PL (1) PL200495B1 (fr)
PT (1) PT1007084E (fr)
TW (1) TWI235666B (fr)
WO (1) WO1999002180A1 (fr)
ZA (1) ZA986074B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
AUPP807399A0 (en) * 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60017211T2 (de) 1999-02-17 2005-06-02 Pfizer Products Inc., Groton Fusionsproteine mit Trägern welche eine doppelte Immunantwort induzieren
US8088734B2 (en) * 2003-01-21 2012-01-03 Unigene Laboratories Inc. Oral delivery of peptides
US20090028886A1 (en) * 2004-08-04 2009-01-29 Cytos Biotechnology Ag Carrier conjugates of gnrh-peptides
MX2007015151A (es) * 2005-06-01 2008-02-15 Pfizer Prod Inc Composiciones de vacunas y metodos para el tratamiento de la incontinencia urinaria.
WO2008110912A1 (fr) * 2007-03-14 2008-09-18 Pfizer Inc. Régulation de fertilité chez des chevaux
MX368898B (es) 2012-12-03 2019-10-21 Pfizer Moduladores selectivos del receptor de androgenos novedosos.
KR101918381B1 (ko) * 2017-01-11 2018-11-13 이경민 칠보 공예품을 제조하는 방법과 이에 의하여 제조되는 칠보 공예품
KR102477054B1 (ko) * 2020-03-24 2022-12-14 주식회사 바이오앱 웅취 제거용 재조합 단백질 및 이를 포함하는 백신 조성물
WO2025010482A1 (fr) * 2023-07-07 2025-01-16 Ouro Fino Saúde Animal Ltda Peptide de gnrh modifié et son conjugué pour l'immunocastration de mammifères, procédé de fabrication, composition et kit

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
DE3411224A1 (de) * 1984-03-27 1985-10-10 Hoechst Ag, 6230 Frankfurt Verfahren zur racematarmen herstellung von peptidzwischenprodukten der gonadorelin- und gonadorelinanaloga-synthese und neue zwischenprodukte bei diesem verfahren
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
NZ221306A (en) 1986-08-15 1990-02-26 Commw Scient Ind Res Org 2-component immunoadjuvant comprising a mycobacterial free immunoadjuvant oil and a polycationic polyelectrolyte immunoadjuvant and vaccines thereof
WO1988005308A1 (fr) * 1987-01-14 1988-07-28 Commonwealth Scientific And Industrial Research Or Hormone contraceptive
GB2228262B (en) * 1989-01-25 1992-10-07 Nat Inst Immunology Antigenic derivative of gnrh
AU5186090A (en) * 1989-02-23 1990-09-26 Colorado State University Research Foundation Gnrh analogs for destroying gonadotrophs
NL8900726A (nl) 1989-03-23 1990-10-16 Stichting Centr Diergeneeskund Peptide, immunogene samenstelling en vaccin- of geneesmiddelpreparaat; werkwijze voor het immuniseren van een zoogdier tegen lhrh, en werkwijze voor het verbeteren van de vleeskwaliteit van varkens.
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5403586A (en) 1989-08-25 1995-04-04 Biotechnology Australia Ptl Ltd. LHRH-TraTp fusion proteins
US5324512A (en) 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
CA2081660C (fr) * 1991-03-01 2001-05-01 Raymond Dufour Methode pour ameliorer les qualites organoleptiques de la viande de verrats et vaccin utilise a cet effet
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
ZA934199B (en) 1992-06-18 1994-01-10 Akzo Nv Carrier system against gnrh
US5614487A (en) 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
USRE39048E1 (en) * 1995-06-07 2006-03-28 Pepscan Systems B.V. Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
ES2163631T3 (es) 1995-06-07 2002-02-01 Dlo Inst Voor Dierhouderij En Un peptido mejorado, composicion inmunogenica y vacuna o preparacion medica, un procedimiento para inmunizar a los animales contra la hormona lhrh, analogos del peptido lhrh repetidos en tandem y su uso como vacuna.
AU7468196A (en) 1995-10-27 1997-05-15 Merck & Co., Inc. Conjugates of gonadotropin releasing hormone
AUPO776897A0 (en) * 1997-07-09 1997-07-31 Csl Limited A method of achieving production gains in livestock and agents useful for same
US6013770A (en) 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines

Also Published As

Publication number Publication date
FR10C0035I1 (fr) 2010-08-27
JP2010059167A (ja) 2010-03-18
CY2010013I1 (el) 2012-01-25
TWI235666B (en) 2005-07-11
CY1109968T1 (el) 2012-01-25
ATE458493T1 (de) 2010-03-15
US8741303B2 (en) 2014-06-03
KR100680631B1 (ko) 2007-02-09
EP1007084A4 (fr) 2003-07-02
US20110293647A1 (en) 2011-12-01
ZA986074B (en) 1999-03-16
FR10C0040I1 (fr) 2010-10-15
DE122010000033I1 (de) 2011-12-01
AU8200198A (en) 1999-02-08
EP2191839A3 (fr) 2010-09-08
JP2001509489A (ja) 2001-07-24
CY2010013I2 (el) 2012-01-25
CA2294865A1 (fr) 1999-01-21
KR20060101554A (ko) 2006-09-25
US20060024290A1 (en) 2006-02-02
EP1007084B1 (fr) 2010-02-24
JP2013006862A (ja) 2013-01-10
US20090226484A1 (en) 2009-09-10
FR10C0035I2 (fr) 2012-06-22
JP5116916B2 (ja) 2013-01-09
WO1999002180A1 (fr) 1999-01-21
AUPO776897A0 (en) 1997-07-31
US7534441B2 (en) 2009-05-19
PL200495B1 (pl) 2009-01-30
PL338037A1 (en) 2000-09-25
US20090291098A1 (en) 2009-11-26
US20120328639A1 (en) 2012-12-27
EP2196213A1 (fr) 2010-06-16
EP1007084A1 (fr) 2000-06-14
KR20010021623A (ko) 2001-03-15
ES2339308T3 (es) 2010-05-18
DK1007084T3 (da) 2010-05-03
DE69841521D1 (de) 2010-04-08
EP2316477A1 (fr) 2011-05-04
AU725562B2 (en) 2000-10-12
US20140271695A1 (en) 2014-09-18
JP5231378B2 (ja) 2013-07-10
PT1007084E (pt) 2010-04-08
EP2191839A2 (fr) 2010-06-02
CA2294865C (fr) 2013-05-21
NZ502080A (en) 2001-09-28

Similar Documents

Publication Publication Date Title
LU91711I2 (fr) Conugé analogue de la gonadolibérine (GnRF-gonadotrophin releasing factor)-anatoxine diphtérique adsorbé sur un polysaccharide ionique ladite gonadolibérine étant également connue sous le nom d'hormone stimulant la sécrétion des hormones gonadotropes(GnRH) ou encore sous le nom d'hormone stimulant la sécrétion de l'hormone luténisante (LHRH)(IMPROVAC).
IL231675A0 (en) Concentrated protein compositions with reduced viscosity
EP2264166A3 (fr) Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle
DK0949907T3 (da) Fremgangsmåder og præparater til forbedret biotilgængelighed og biologisk aktive midler til slimhindeadministration
WO2003079972A3 (fr) Systemes de distribution d'agents actifs et methodes de protection et d'administration d'agents actifs
JO2034B1 (en) Isotopes of the hormone peptide its uses and the chemical compounds it contains
AU4991599A (en) Method of vaccination of newly hatched poultry
AU6945491A (en) Pimobendan compositions
EP1952819A3 (fr) Procédé de prévention de la gastrite au moyen d'amyline ou d'agonistes d'amyline
WO2002030357A3 (fr) Composes et procedes servant a moduler la fonction de ccr4
ATE119398T1 (de) Pharmazeutische zusammensetzungen.
HUT58467A (en) Treatment of concrete roofing elements with microbiocidal agent
CA2296560A1 (fr) Derives d'acides amines pour le traitement des accidents cerebrovasculaires
AR008898A1 (es) Procedimiento convergente para la preparacion de un secretagogo de hormona de crecimiento.
EP0919621A4 (fr) Tak1 humaine et adn codant celle-ci
IL84327A0 (en) Pharmaceutical compositions comprising somatostatin
WO2000044393A3 (fr) Systeme d'administration orale de medicaments proteiniques
WO2000018385A3 (fr) Compositions pharmaceutiques possedant une activite antitumorale
Braun Language-A Transubstantiated Vision Into Etemity
RU97120474A (ru) Биологически активная кормовая добавка для сельскохозяйственных птиц
RU96103806A (ru) Удобрительный состав
UA43480A (uk) Кормова добавка для поросят після відлучення
IT1274012B (it) N-acetiltriptamine-2-sostituite, antagoniste ad elevata affinita' del recettore della melatonina
BG103873A (en) The use of protein-containing microparticles with adsorbed antibody for the preparation of pharmaceutical composition for intranasal administration
ES1035937U (es) Regadera.